Data / Federal rules / 2025-14206
TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments
The Defense Department published this final rule in the Federal Register on July 28, 2025. It took effect on August 27, 2025.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The Assistant Secretary of Defense for Health Affairs (ASD(HA)) issues this final rule regarding circumstances under which services and supplies related to emerging treatments may be covered under the TRICARE program. This rule finalizes provisions published in two interim final rules (IFRs) with request for comment, which temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. This final rule discusses the DoD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. Lastly, the final rule expands TRICARE's clinical trial benefit by covering services and supplies provided in conjunction with Phase I, II, III, and IV clinical trials that are NIH-sponsored or approved and that involve a new treatment or cure for a specific condition or the treatment of a currently uncontrolled symptom or aspect of that condition, provided that the condition is severely debilitating, life- threatening, or a rare disease.
Key facts
- Document number
- 2025-14206
- Type
- Final rule
- Action
- Final rule
- Agency
- Defense Department
- Published
- July 28, 2025
- Takes effect
- August 27, 2025
- Dates
- This rule is effective on August 27, 2025.
- Docket
- Docket ID: DOD-2020-HA-0050
- Regulation ID (RIN)
- 0720-AB83
- Code of Federal Regulations
- 32 CFR 199
- Topics
- Administrative practice and procedure; Claims; Fraud; Health care; Health insurance; Individuals with disabilities; Mental health programs; Military personnel
- Pages
- 13
Other documents from the Defense Department
Everything from the Defense Department · Rules on administrative practice and procedure · Rules on claims · Rules on fraud · Published in July 2025
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.